Opaleye Management Inc.'s Form 4 filing
Protara Therapeutics, Inc. (TARA) · filed May 17, 2024
- Accession no.
- 0001493152-24-020507
- Filed
- May 17, 2024
- Trade date
- May 17, 2024
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $230.4K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −47,250 | $3.33 | −$157,342.5 | 2,333,044 | Indirect | |
| May 17, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −19,685 | $3.06 | −$60,236.1 | 2,313,359 | Indirect | |
| May 17, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −2,750 | $3.33 | −$9,157.5 | 127,250 | Indirect | |
| May 17, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −1,200 | $3.06 | −$3,672 | 126,050 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.